Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAPGEF4 | Q8WZA2 | 11/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27516695 | 0.97 | RAPGEF4 (0.52) | RAPGEF4TSHRCYP3A4RECQLFFAR4 | |
| SCHEMBL14002878 | 0.85 | FFAR4 (0.47) | RAPGEF4TSHRCYP3A4RECQLFFAR4 | |
| SCHEMBL24348160 | 0.84 | RAPGEF4 (0.52) | RAPGEF4TSHRCYP3A4RECQLFFAR4 | |
| SCHEMBL8294250 | 0.84 | TSHR (0.56) | RAPGEF4TSHRLMNAALDH1A1HPGD | |
| SCHEMBL12909372 | 0.84 | RAPGEF4 (0.44) | RAPGEF4TSHRCYP3A4RECQLFFAR4 | |
| SCHEMBL2756366 | 0.81 | RAPGEF4 (0.57) | RAPGEF4CYP3A4FFAR4LMNAALDH1A1 | |
| SCHEMBL12963494 | 0.80 | RAPGEF4 (0.50) | RAPGEF4TSHRFFAR4LMNAALDH1A1 | |
| SCHEMBL12852100 | 0.80 | ALDH1A1 (0.43) | RAPGEF4TSHRCYP3A4RECQLALDH1A1 | |
| SCHEMBL8285137 | 0.80 | TAAR1 (0.40) | TSHRCYP3A4RECQLFFAR4 | |
| SCHEMBL13073787 | 0.78 | METAP2 (0.53) | RAPGEF4TSHRLMNAALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200369689-A1 | Arylaminosilane Compound, Propylene Polymerization Catalyst And Preparation Thereof | PETROCHINA COMPANY LIMITED (CN) | 2020-11-26 | — | — | US | claimed |
| CN-111978346-A | Arylamine silane compound, propylene polymerization catalyst, preparation and application thereof | 中国石油天然气股份有限公司 | 2020-11-24 | — | — | CN | claimed |
| US-11655371-B2 | Color material dispersion liquid, color resin composition, color filter, liquid crystal display device, and light-emitting display device | DAI NIPPON PRINTING CO., LTD. (JP) | 2023-05-23 | — | — | US | disclosed |
| US-11535638-B2 | Arylaminosilane compound, propylene polymerization catalyst and preparation thereof | PETROCHINA COMPANY LIMITED (CN) | 2022-12-27 | — | — | US | disclosed |
| WO-2022087121-A1 | MULTIDENTATE LEWIS BASE CATALYSTS AND METHODS FOR USE THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2022-04-28 | — | — | WO | disclosed |
| CN-109415298-B | Compounds and intermediates thereof | 大日本印刷株式会社 | 2022-03-29 | — | — | CN | disclosed |
| US-20210324200-A1 | COLOR MATERIAL DISPERSION LIQUID, COLOR RESIN COMPOSITION, COLOR FILTER, LIQUID CRYSTAL DISPLAY DEVICE, AND LIGHT-EMITTING DISPLAY DEVICE | DAI NIPPON PRINTING CO., LTD. (JP) | 2021-10-21 | — | — | US | disclosed |
| WO-2021188361-A1 | LINEAR ALPHA-OLEFIN COPOLYMERS AND IMPACT COPOLYMERS THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2021-09-23 | — | — | WO | disclosed |
| WO-2021162745-A1 | PROPYLENE COPOLYMERS OBTAINED USING TRANSITION METAL BIS(PHENOLATE) CATALYST COMPLEXES AND HOMOGENEOUS PROCESS FOR PRODUCTION THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2021-08-19 | — | — | WO | disclosed |
| US-11084934-B2 | Color material dispersion liquid, color resin composition, color filter, liquid crystal display device, and light-emitting display device | DAI NIPPON PRINTING CO., LTD. (JP) | 2021-08-10 | — | — | US | disclosed |
| WO-2021034459-A1 | ISOTACTIC PROPYLENE HOMOPOLYMERS AND COPOLYMERS PRODUCED WITH C1 SYMMETRIC METALLOCENE CATALYSTS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2021-02-25 | — | — | WO | disclosed |
| US-20070093502-A1 | 5- Or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication | BONFANTI JEAN-FRANCOIS | 2007-04-26 | — | — | US | disclosed |
| US-20070093502-A1 | 5- Or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication | BONFANTI JEAN-FRANCOIS | 2007-04-26 | — | — | US | disclosed |
| EP-1725562-A1 | PYRROLOPYRIMIDINE DERIVATIVES | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2006-11-29 | — | — | EP | disclosed |
| CN-1265881-C | High activity metal carbene metathesis catalysts prepared using thermally activated N-heterocyclic carbene precursors | CALIFORNIA INST OF TECHN (US) | 2006-07-26 | — | — | CN | disclosed |
| WO-2005085253-A1 | PYRROLOPYRIMIDINE DERIVATIVES | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2005-09-15 | — | — | WO | disclosed |
| WO-2005058874-A1 | 5- OR 6-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION | TIBOTEC PHARMACEUTICALS LTD. (IE) | 2005-06-30 | — | — | WO | disclosed |
| CN-1511064-A | High activity metal carbene metathesis catalysts prepared using thermally activated N-heterocyclic carbene precursors | ����ʯ��ѧԺ | 2004-07-07 | — | — | CN | disclosed |
| WO-2003024448-A2 | INHIBITORS OF HISTONE DEACETYLASE | METHYLGENE, INC. (CA) | 2003-03-27 | — | — | WO | disclosed |
| WO-1995006642-A1 | MALODINITRIL-SUBSTITUTED 1,3,5-TRIAZIN-DIAMINES WITH HERBICIDAL ACTIVITY | BAYER AKTIENGESELLSCHAFT (DE) | 1995-03-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11535638-B2 | Arylaminosilane compound, propylene polymerization catalyst and preparation thereof | RPS8, PARP8, PRMT8 | RAPGEF4 668/4885TSHR 912/4885CYP3A4 1230/4885 |
| US-20070093502-A1 | 5- Or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, SUB1, HYOU1 | RAPGEF4 4220/4885TSHR 2810/4885CYP3A4 1242/4885 |
| US-20200369689-A1 | Arylaminosilane Compound, Propylene Polymerization Catalyst And Preparation Thereof | RPS8, PARP8, PRMT8 | RAPGEF4 668/4885TSHR 912/4885CYP3A4 1230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.